Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)
Titel:
Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)
Auteur:
Fineberg, Naomi A. Hollander, Eric Grant, Jon E. Chamberlain, Samuel R. Drummond, Lynne M. Pellegrini, Luca Laws, Keith R. Wellsted, David Reid, Jemma Nezgovorova, Vera Baldwin, David S.